SR

Srinivasa Ramachandra Rao Ilapakurthy

Active Director Director DIN 07878237
DIN 07878237 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2023
Shareholding value •••• Premium profile

About Srinivasa Ramachandra Rao Ilapakurthy

Data last updated:

Srinivasa Ramachandra Rao Ilapakurthy is a Director at Gls Pharma Limited (since 2023), Director at Lyfius Pharma Private Limited (since 2024) and Director at Auro Pharma Limited (since 2023). The companies operate in Pharma, Chemicals and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹36.10 Cr; the largest is Gls Pharma Limited at ₹36.08 Cr (FY 2023). Earlier, Srinivasa Ramachandra Rao Ilapakurthy was a Designated Partner at Service First Experts Llp (2023).

DIN 07878237
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2023
Oldest Company Age 22 yrs
Largest company Gls Pharma Limited · ₹36.08 Cr (FY 2023)
Combined revenue ₹36.10 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gls Pharma Limited U24239TS2004PLC184306
Director15 Dec 20232004₹36.08 Cr (FY 2023)Active
Lyfius Pharma Private Limited U24299AP2020PTC116443
Director30 Jan 20242020₹2 Lakh (FY 2023)Active
Auro Pharma Limited U46497TS2023PLC179262
Director22 Nov 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Jan 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lyfius Pharma Private Limited
Gls Pharma Limited
Auro Pharma Limited
Service First Experts Llp
Premium access

Shareholding and investment profile for Srinivasa Ramachandra Rao Ilapakurthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Ramachandra Rao Ilapakurthy

Srinivasa Ramachandra Rao Ilapakurthy currently holds 3 directorships: Gls Pharma Limited (Director, since 15 Dec 2023, revenue ₹36.08 Cr (FY 2023)); Lyfius Pharma Private Limited (Director, since 30 Jan 2024, revenue ₹2 Lakh (FY 2023)); Auro Pharma Limited (Director, since 22 Nov 2023).

Srinivasa Ramachandra Rao Ilapakurthy was first appointed on 16 Jan 2023 as Designated Partner at Service First Experts Llp. The most recent appointment on record is 30 Jan 2024 at Lyfius Pharma Private Limited.

The 2 current companies of Srinivasa Ramachandra Rao Ilapakurthy that report revenue have a combined latest revenue of ₹36.10 Cr: Gls Pharma Limited ₹36.08 Cr (FY 2023); Lyfius Pharma Private Limited ₹2 Lakh (FY 2023).

Srinivasa Ramachandra Rao Ilapakurthy held 1 earlier board appointment: Service First Experts Llp (Designated Partner, 16 Jan 2023 to 07 Jul 2023).

The current boards of Srinivasa Ramachandra Rao Ilapakurthy's companies include Pendem Harish Babu (Gls Pharma Limited), Ravikiran Namburi (Gls Pharma Limited), Bala Subramanyam Sami Reddy Palle Reddy (Lyfius Pharma Private Limited), Medisetti Venkata Ramakrishna (Lyfius Pharma Private Limited), Nityananda Reddy Kambam (Lyfius Pharma Private Limited), Santhanam Subramanian (Lyfius Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available